Genesis Molecular AI · 1 month ago
Staff / Principal Software Engineer
Genesis Therapeutics is building a world-class software team to solve problems in drug discovery through machine learning and computational chemistry. They are seeking a staff or principal software engineer to provide technical leadership and help develop their software platform.
Artificial Intelligence (AI)BiotechnologyInformation Technology
Responsibilities
Provide technical insights to the head of engineering and head of computational chemistry on software architecture
Help scale our data infrastructure to handle billions of datapoints and hundreds of thousands of parallel quantum chemistry and molecular dynamics jobs
Lead, mentor and coach engineers - both from chemistry and computer science backgrounds
Qualification
Required
Provide technical insights to the head of engineering and head of computational chemistry on software architecture
Help scale our data infrastructure to handle billions of datapoints and hundreds of thousands of parallel quantum chemistry and molecular dynamics jobs
Lead, mentor and coach engineers - both from chemistry and computer science backgrounds
A deep thinker who reasons from first principles, balances attention to detail with architectural thinking, and has an investigational curiosity to find the root cause of a problem
Comfortable working across all levels of the software stack and building intuitive APIs
Master of writing production code and driving projects to completion
Benefits
Medical, dental, and vision insurance
401(k) program
Company
Genesis Molecular AI
Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.
H1B Sponsorship
Genesis Molecular AI has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (1)
2023 (1)
2022 (1)
Funding
Current Stage
Growth StageTotal Funding
$256.1MKey Investors
Andreessen HorowitzRock Springs Capital
2023-08-21Series B· $200M
2020-12-02Series A· $52M
2020-04-01Series Unknown
Recent News
Genetic Engineering News
2025-12-10
MIT Technology Review
2025-11-27
Company data provided by crunchbase